• VOLUNTARY ANNOUNCEMENT - Admission to Special Examination and Approval Procedure for Innovative Medical Devices in respect of Thoracoabdominal Artery Stent Graft System

   

• VOLUNTARY ANNOUNCEMENT - Announcement of the two-year follow-up results of the FIM clinical trial of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2021

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2021

   

• POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 17 SEPTEMBER 2021

   

• VOLUNTARY ANNOUNCEMENT - LAxibleTM obtained official registration approval by the China NMPA

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2021

   

• INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021

   

• NOTICE OF EXTRAORDINARY GENERAL MEETING

   

• Form of proxy for use at Extraordinary General Meeting to be held on Friday, 17 September 2021 or any adjournment thereof